Advanced search

A phase I first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies

(2014) JOURNAL OF CLINICAL ONCOLOGY. 32(15, suppl.).
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Awada, Ahmad, Christian D Rolfo, Sylvia Rottey, Laure Ysebrant de Lendonck, Wilfrled A Schroyens, Fritz Offner, Karen Silence, et al. 2014. “A Phase I First-in-human Study of ARGX-110, a Monoclonal Antibody Targeting CD70, a Receptor Involved in Immune Escape and Tumor Growth in Patients with Solid and Hematologic Malignancies.” In Journal of Clinical Oncology. Vol. 32.
APA
Awada, A., Rolfo, C. D., Rottey, S., de Lendonck, L. Y., Schroyens, W. A., Offner, F., Silence, K., et al. (2014). A phase I first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies. JOURNAL OF CLINICAL ONCOLOGY (Vol. 32). Presented at the 50th Annual meeting of the American Society of Clinical Oncology.
Vancouver
1.
Awada A, Rolfo CD, Rottey S, de Lendonck LY, Schroyens WA, Offner F, et al. A phase I first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies. JOURNAL OF CLINICAL ONCOLOGY. 2014.
MLA
Awada, Ahmad, Christian D Rolfo, Sylvia Rottey, et al. “A Phase I First-in-human Study of ARGX-110, a Monoclonal Antibody Targeting CD70, a Receptor Involved in Immune Escape and Tumor Growth in Patients with Solid and Hematologic Malignancies.” Journal of Clinical Oncology. Vol. 32. 2014. Print.
@inproceedings{7004678,
  articleno    = {abstract 3023},
  author       = {Awada, Ahmad and Rolfo, Christian D and Rottey, Sylvia and de Lendonck, Laure Ysebrant and Schroyens, Wilfrled A and Offner, Fritz and Silence, Karen and Dreier, Torsten and Moshir, Mahan and de Heard, Hans and Posters, Marc and Bron, Dominique and Thibault, Alain and Aftimos, Philippe G},
  booktitle    = {JOURNAL OF CLINICAL ONCOLOGY},
  issn         = {0732-183X},
  language     = {eng},
  location     = {Chicago, IL, USA},
  number       = {15, suppl.},
  title        = {A phase I first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies},
  volume       = {32},
  year         = {2014},
}

Web of Science
Times cited: